| Literature DB >> 9473374 |
Abstract
Recent studies have demonstrated increased numbers of gammadelta T cells in a variety of human infectious as well as noninfectious diseases. In some cases gammadelta T cells could be shown to destroy infected or transformed cells. Advances in the identification of ligands recognized by gammadelta T cells and the development of animal model systems to study these cells in vivo should overcome some of the major obstacles currently preventing a better understanding of gammadelta T cell function in immune responses. As we gain this knowledge it may become possible to design therapeutic strategies exploiting unique properties of gammadelta T cells to promote more effective immunity. Copyright 1998 Academic Press.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9473374 DOI: 10.1006/clin.1997.4468
Source DB: PubMed Journal: Clin Immunol Immunopathol ISSN: 0090-1229